BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24468566)

  • 1. Ongoing issues in the intensive care for the periviable infant--nutritional management and prevention of bronchopulmonary dysplasia and nosocomial infections.
    Ehrenkranz RA
    Semin Perinatol; 2014 Feb; 38(1):25-30. PubMed ID: 24468566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Biniwale MA; Ehrenkranz RA
    Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years.
    Theile AR; Radmacher PG; Anschutz TW; Davis DW; Adamkin DH
    J Perinatol; 2012 Feb; 32(2):117-22. PubMed ID: 21617642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Control Trial of Human Recombinant Lactoferrin: A Substudy Reveals Effects on the Fecal Microbiome of Very Low Birth Weight Infants.
    Sherman MP; Sherman J; Arcinue R; Niklas V
    J Pediatr; 2016 Jun; 173 Suppl():S37-42. PubMed ID: 27234409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional management of infants with bronchopulmonary dysplasia.
    Reimers KJ; Carlson SJ; Lombard KA
    Nutr Clin Pract; 1992 Jun; 7(3):127-32. PubMed ID: 1289684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of introduction of synchronized nasal intermittent positive-pressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infants.
    Kulkarni A; Ehrenkranz RA; Bhandari V
    Am J Perinatol; 2006 May; 23(4):233-40. PubMed ID: 16625501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management during the first 72 h of age of the periviable infant: an evidence-based review.
    Barrington KJ
    Semin Perinatol; 2014 Feb; 38(1):17-24. PubMed ID: 24468565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special circumstances: trophic feeds, necrotizing enterocolitis and bronchopulmonary dysplasia.
    Reynolds RM; Thureen PJ
    Semin Fetal Neonatal Med; 2007 Feb; 12(1):64-70. PubMed ID: 17189719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition and outpatient management of the very low-birth-weight infant with bronchopulmonary dysplasia.
    Groothuis JR; Makari D
    Adv Ther; 2012 Apr; 29(4):297-311. PubMed ID: 22529025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Benefits of Lactoferrin for Infants and Children.
    Manzoni P
    J Pediatr; 2016 Jun; 173 Suppl():S43-52. PubMed ID: 27234411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship of Nosocomial Infection Reduction to Changes in Neonatal Intensive Care Unit Rates of Bronchopulmonary Dysplasia.
    Lapcharoensap W; Kan P; Powers RJ; Shaw GM; Stevenson DK; Gould JB; Wirtschafter DD; Lee HC
    J Pediatr; 2017 Jan; 180():105-109.e1. PubMed ID: 27742123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counseling pregnant women who may deliver extremely premature infants: medical care guidelines, family choices, and neonatal outcomes.
    Kaempf JW; Tomlinson MW; Campbell B; Ferguson L; Stewart VT
    Pediatrics; 2009 Jun; 123(6):1509-15. PubMed ID: 19482761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA; Harrison M; Clark RH
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Fanaroff AA; Korones SB; Wright LL; Wright EC; Poland RL; Bauer CB; Tyson JE; Philips JB; Edwards W; Lucey JF
    N Engl J Med; 1994 Apr; 330(16):1107-13. PubMed ID: 8133853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year experience with neonatal ventilation from a tertiary care hospital in Delhi.
    Singh M; Deorari AK; Paul VK; Mittal M; Shanker S; Munshi U; Jain Y
    Indian Pediatr; 1993 Jun; 30(6):783-9. PubMed ID: 8132260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized behavioral and environmental care for the very low birth weight preterm infant at high risk for bronchopulmonary dysplasia: neonatal intensive care unit and developmental outcome.
    Als H; Lawhon G; Brown E; Gibes R; Duffy FH; McAnulty G; Blickman JG
    Pediatrics; 1986 Dec; 78(6):1123-32. PubMed ID: 3786036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and development of potentially better practices to reduce bronchopulmonary dysplasia in very low birth weight infants.
    Payne NR; LaCorte M; Sun S; Karna P; Lewis-Hunstiger M; Goldsmith JP;
    Pediatrics; 2006 Nov; 118 Suppl 2():S65-72. PubMed ID: 17079625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.